Analyst Ratings for Eastman Chemical (EMN)
EMN Rating Summary
EMN Price Target Summary
- Highest: $125.00 (Wells Fargo)
- Lowest: $46.00 (Barclays)
- Average: $72.69
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$72.69 (+0.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/1/2013 | CLSA | Downgrade | Outperform (Buy) |
75.00 (90.00) |
66.65 | 72.44 | 8.69% | Details |
| 4/29/2013 | JPMorgan | Downgrade | Neutral (Overweight) |
70.00 (79.00) |
68.97 | 72.44 | 5.03% | Details |
| 12/14/2012 | SunTrust Robinson Humphrey | New Coverage | Buy (N/A) |
79.00 (N/A) |
63.76 | 72.44 | 13.61% | Details |
| 11/27/2012 | KeyBanc | New Coverage | Buy (N/A) |
74.00 (N/A) |
59.25 | 72.44 | 22.26% | Details |
| 10/8/2012 | Gilford Securities | Downgrade | Hold (Buy) |
N/A (N/A) |
59.13 | 72.44 | 22.51% | Details |
| 10/8/2012 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
59.13 | 72.44 | 22.51% | Details |
| 9/19/2012 | RBC Capital | New Coverage | Sector Perform (N/A) |
66.00 (N/A) |
57.55 | 72.44 | 25.87% | Details |
| 9/11/2012 | Jefferies » Updated 2/8/2013 |
New Coverage | Hold (N/A) |
79.00 (71.00) |
57.17 | 72.44 | 26.71% | Details |
| 7/26/2012 | Lazard Capital | New Coverage | Buy (N/A) |
67.00 (N/A) |
48.48 | 72.44 | 49.42% | Details |
| 7/3/2012 | Citi | Upgrade | Buy (Neutral) |
N/A (N/A) |
49.72 | 72.44 | 45.7% | Details |
| 4/9/2012 | Goldman Sachs » Updated 6/21/2012 |
Upgrade | Conviction Buy (N/A) |
57.00 (58.00) |
52.08 | 72.44 | 39.09% | Details |
| 1/27/2012 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
64.00 (N/A) |
49.49 | 72.44 | 46.37% | Details |
| 11/10/2011 | Ticonderoga | New Coverage | Buy (N/A) |
56.00 (N/A) |
39.03 | 72.44 | 85.6% | Details |
| 9/29/2011 | Credit Agricole | New Coverage | Buy (N/A) |
87.00 (N/A) |
69.58 | 72.44 | 4.11% | Details |
| 8/31/2011 | Barclays » Updated 11/18/2011 |
New Coverage | Equalweight (N/A) |
46.00 (N/A) |
82.99 | 72.44 | -12.71% | Details |
